Actually, medical progress has resulted in the increase of survival rates among cancer patients, despite an increase in metastatic lesions. Among the different tumors, bone metastasis is the second most common site of metastases, and secondary spine lesions can be found in approximately 30% of cancers patients. In such case spinal involvement of secondary lesions can be painful or associated with neurologic manifestations. In some instances, especially regarding to osteolytic metastases, symptoms can be grave and clinical conditions very poor when spinal cord compression by a pathologic fracture in the cervical spine occurs.
In such case, when appropriate systemic treatment for the underlying cancer fails, usually hormonal treatment or chemotherapy, patients should be considered for specific treatment, the principal modalities being radiotherapy and bisphosphonates. But, unfortunately, these therapies leave approximately one third of cases with inadequate or undermanaged pain control. This failure prompted the search for other strategies aimed at bone pain control.
In metastatic spinal disease, Percutaneous Vertebroplasty (percutaneous injection of acrylic bone cement into a vertebral body lesion) is gaining acceptance as a minimally invasive procedure for pain control and is effective in approximately 90% of the patients. Besides increasing strength and stiffness of the vertebral body, Percutaneous Vertebroplasty is important for the prevention of further vertebral collapse and spinal cord compression, both of which can be life-threatening when metastases occur in the cervical spine. In some selected cases Percutaneous Vertebroplasty can be proposed in traumatic fractures of the cervical spine (usually the odontoid process of C2) in old patients when conservative treatment fails (due to concomitant high-grade osteoporosis) and surgical fixation is contraindicated.
Percutaneous vertebroplasty can be performed in the upper cervical spine (C1; C2) either by a direct transoral or an anterolateral approach whereas this approach could be anterolateral or posterolateral (depending upon tumoral vertebral involvement) in the lower cervical spine (from C3 to C7); from a technical point of view, these approaches are much more difficult compared with that of transpedicular percutaneous vertebroplasty in the thoracic and lumbar spine because of potential dangerous complications related to the spinal cord, jugular vein, cranial nerves, carotid artery, and vertebral artery. For a safer procedure, combined Computed Tomography (CT) and Digital Fluoroscopy (DF) guidance can be useful when Percutaneous Vertebroplasty is performed in the cervical spine. CT allows precise needle positioning into the lesion and avoids puncture of vital structure (artery, spinal cord, etc.), DF is mandatory for real-time monitoring of bone cement injection.
Percutaneous Vertebroplasty in the cervical spine can be performed under local anesthesia or light sedation in most case, general anesthesia is required when a direct transoral approach is used.
In our personal experience, 38 patients (15 males and 23 females, mean age 65±18 years) underwent PV on 46 cervical vertebrae for painful lesions not responding to conservative treatment (metastases and symptomatic angioma) or because surgery was contraindicated (trauma). All traumatic fractures (6 cases) and the symptomatic angioma (1 case) were located on C2 odontoid process.
The remnant 31 pts suffered from lityc painful metastases from breast cancer (C1-3 lesions; C2-7 lesions; C4; C5-2 lesions), renal cancer (C2; C5; C6), thyroid cancer (C2; C4), oropharingeal cancer (C2-2 lesions; C3; C5), hepatocellular carcinoma (C2), gastric cancer (C2; C3; C5-3 lesions; C6-3 lesions), lung cancer (C7-2 lesions), sarcoma (C2), feocromocytoma (C4), hiystiocitosis X (C2) and myeloma (C2-2 lesions; C4). PV with transoral approach was performed in general anesthesia in all case of C2 and two cases of C1 whereas the other cervical vertebrae were treated in antero-(18), postero-(1) or latero-lateral (1) approach in local anesthesia. Monitoring of heart rate and pulse oximetry was carried out continuously throughout all the procedure. Prophylactic antibiotic therapy with a third-generation cephalosporine before the procedure and for 5 days after the procedure was applied.
All procedures were successfully performed without any major complications. Pts with symptomatic angioma and trauma reported complete pain relief; this clinical result was stable during long-term follow-up (4 years) although CT demonstrated a pseudoarthrosis in 1 pt. Pts with malignancy reported significant pain relief (mean VAS of 7,6±2,1 dropped to 1,8±2,2 p< .0001 paired t-Test) during average follow-up of 12 months. 1 pt with thyroid cancer metastases required posterior surgical fixation 3 months after PV. 1 pt with huge breast cancer metastasis of C2 did not report any pain regression after PV. 37 out of 38 patients (97,4%) decreased analgesic assumption after PV and could dismiss external neck brace support.
PV in the cervical spine requires an overnight hospitalization only when perfomed in the upper cervical spine whereas a day-surgery only is sufficient for patients treated in the lower cervical spine.
With adequate physicians experience and radiological guidance systems, Percutaneous Vertebroplasty in the cervical spine is feasible, safe and effective either in benign or in malignant painful lesions. This therapeutic option should be proposed if conservative treatments fail or if surgery is contraindicated.
